These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27333187)

  • 1. Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    Suzuki-Kemuriyama N; Matsuzaka T; Kuba M; Ohno H; Han SI; Takeuchi Y; Isaka M; Kobayashi K; Iwasaki H; Yatoh S; Suzuki H; Miyajima K; Nakae D; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    PLoS One; 2016; 11(6):e0157580. PubMed ID: 27333187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet-Induced Accumulation of Lipid in the Liver of ApoE
    Liu L; Hu Q; Wu H; Wang X; Gao C; Chen G; Yao P; Gong Z
    Oxid Med Cell Longev; 2018; 2018():6256802. PubMed ID: 30538803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.
    Depner CM; Philbrick KA; Jump DB
    J Nutr; 2013 Mar; 143(3):315-23. PubMed ID: 23303872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
    Kelley NS
    Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice.
    Shang T; Liu L; Zhou J; Zhang M; Hu Q; Fang M; Wu Y; Yao P; Gong Z
    Lipids Health Dis; 2017 Mar; 16(1):65. PubMed ID: 28356106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice.
    Soni NK; Nookaew I; Sandberg AS; Gabrielsson BG
    Lipids Health Dis; 2015 Jul; 14():74. PubMed ID: 26193881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis.
    Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M
    Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of EPA, DPA and DHA on cardio-metabolic risk factors in high-fat diet fed mice.
    Guo XF; Sinclair AJ; Kaur G; Li D
    Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():47-55. PubMed ID: 29113747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice.
    Valenzuela R; Echeverria F; Ortiz M; Rincón-Cervera MÁ; Espinosa A; Hernandez-Rodas MC; Illesca P; Valenzuela A; Videla LA
    Lipids Health Dis; 2017 Apr; 16(1):64. PubMed ID: 28395666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. n-3 polyunsaturated fatty acids in phospholipid or triacylglycerol form attenuate nonalcoholic fatty liver disease via mediating cannabinoid receptor 1/adiponectin/ceramide pathway.
    Chen YF; Fan ZK; Gao X; Zhou F; Guo XF; Sinclair AJ; Li D
    J Nutr Biochem; 2024 Jan; 123():109484. PubMed ID: 37866428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DHA supplementation prevent the progression of NASH via GPR120 signaling.
    Nakamoto K; Shimada K; Harada S; Morimoto Y; Hirasawa A; Tokuyama S
    Eur J Pharmacol; 2018 Feb; 820():31-38. PubMed ID: 29221950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ewe early gestation supplementation with eicosapentaenoic and docosahexaenoic acids affects the liver, muscle, and adipose tissue fatty acid profile and liver mRNA expression in the offspring.
    Roque-Jiménez JA; Oviedo-Ojeda MF; Whalin M; Lee-Rangel HA; Relling AE
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37158288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells.
    Albracht-Schulte K; Gonzalez S; Jackson A; Wilson S; Ramalingam L; Kalupahana NS; Moustaid-Moussa N
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30871035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.
    Jump DB; Depner CM; Tripathy S; Lytle KA
    Adv Nutr; 2015 Nov; 6(6):694-702. PubMed ID: 26567194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Omega-3 Fatty Acids EPA and DHA, as a Part of a Murine High-Fat Diet, Reduced Lipid Accumulation in Brown and White Adipose Tissues.
    Soni N; Ross AB; Scheers N; Nookaew I; Gabrielsson BG; Sandberg AS
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet.
    Valenzuela R; Espinosa A; Llanos P; Hernandez-Rodas MC; Barrera C; Vergara D; Romero N; Pérez F; Ruz M; Videla LA
    Food Funct; 2016 Jan; 7(1):140-50. PubMed ID: 26471014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic Acid Modulates Nonalcoholic Fatty Liver Disease by Suppressing Endocannabinoid System.
    Chen YF; Fan ZK; Wang YP; Liu P; Guo XF; Li D
    Mol Nutr Food Res; 2024 Apr; 68(7):e2300616. PubMed ID: 38430210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPA and DHA elicit distinct transcriptional responses to high-fat feeding in skeletal muscle and liver.
    Kunz HE; Dasari S; Lanza IR
    Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E460-E472. PubMed ID: 31265326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.